MyHealthChecked Plc
("MyHealthChecked" or the "Company")
Director/PDMR Shareholding
Non-Executive Chairman buys 1m shares
MyHealthChecked plc (AIM:MHC), the consumer home-testing healthcare company, announces that it was notified that on 3 August 2022 Adam Reynolds, Non-Executive Chairman, purchased a total of 1,000,000 (one million) ordinary shares of 0.1 pence each in the Company ("Ordinary Shares") at a price of 1.7 pence per Ordinary Share.
Following this transaction, Adam Reynolds' total direct and indirect interest in the Company is 10,513,293 Ordinary Shares representing approximately 1.35% of the Group's total issued share capital.
The Notification of Dealing Form required in accordance with UK MAR is set out below.
For further information contact:
MyHealthChecked plc |
||
Penny McCormick, Chief Executive Officer |
via Walbrook PR |
|
|
|
|
SPARK Advisory Partners Limited (NOMAD) |
Tel: +44 (0)20 3368 3550 |
|
Neil Baldwin |
|
|
|
|
|
Oberon Capital Ltd (Broker) |
Tel: +44 (0)20 3179 5344 |
|
Mike Seabrook |
||
|
|
|
Walbrook PR Ltd (Media & IR) |
Tel: +44 (0)20 7933 8780 or myhealthcheckedplc@walbrookpr.com |
|
Paul McManus / Alice Woodings |
Mob: +44 (0)7980 541 893 / +44 (0)7407 804 654 |
|
About MyHealthChecked PLC ( www.myhealthcheckedplc.com )
MyHealthChecked PLC, based in Cardiff, is an AIM-quoted pioneering UK healthcare company focused on a range of at-home healthcare and wellness tests.
MyHealthChecked is the umbrella brand of a range of at-home DNA and RNA tests that have been developed following the acquisition of The Genome Store in November 2020. The tests are available online, and in some cases, for over-the-counter purchase.
The MyHealthChecked portfolio has been identified as part of a change in mindset as customers become more familiar with the concept of accessible healthcare in the growing at home testing kit market with a focus on accessibility at the right price, led by UK-based experts.
Notification and public disclosure of transactions by persons discharging managerial responsibilities ("PDMRs") and persons closely associated ("PCA") with them.
1
|
Details of the person discharging managerial responsibilities / person closely associated
|
||||
a)
|
Name
|
Adam Reynolds |
|||
2
|
Reason for the notification
|
||||
a)
|
Position/status
|
Non-Executive Chairman |
|||
b)
|
Initial notification /Amendment
|
Initial Notification |
|||
3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
||||
a)
|
Name
|
MYHEALTHCHECKED plc |
|||
b)
|
LEI
|
213800RBHY6LZDG13168
|
|||
CO4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
||||
a)
|
Description of the financial instrument, type of instrument |
Ordinary Shares
|
|||
|
|
||||
Identification code |
ISIN: GB00BYZ2R301 |
||||
|
|
||||
b)
|
Nature of the transaction
|
Purchase of Ordinary Shares |
|||
c)
|
Price(s) and volume(s) |
|
|
|
|
|
|
Price(s) |
Volume(s) |
|
|
|
|
1.7 pence |
1,000,000 |
|
|
|
|
|
|
|
|
d)
|
Aggregated information |
|
|||
|
|
||||
- Aggregated volume |
N/A - Single Transaction |
||||
|
|
||||
- Price |
|
||||
|
|
||||
e)
|
Date of the transaction
|
3 August 2022 |
|||
f)
|
Place of the transaction
|
London Stock Exchange - AIMX |